MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Recruiting Phase 2 Interventional Study
Post Traumatic Stress Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Stephen Robert Marder · Federal
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * At Screening, meet DSM-5 criteria for current PTSD with a symptom duration of at least 6 months. * Fluent in speaking and reading the predominantly used or recognized language of the study site (English). * Must be a veteran enrolled at a VA Healthcare Center in the Greater Lo…
Contacts

Stephanie L Taylor, PhD

213-505-1140

Stephanie.Taylor8@va.gov

CONTACT

Stephen Marder, MD

Stephen.Marder@va.gov

CONTACT